Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenon Pharmaceuticals Total Assets 2012-2020 | XENE

Xenon Pharmaceuticals total assets from 2012 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Xenon Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $148
2018 $122
2017 $46
2016 $67
2015 $64
2014 $87
2013 $54
2012 $63
2011 $0
Xenon Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2020-03-31 $237
2019-12-31 $148
2019-09-30 $99
2019-06-30 $106
2019-03-31 $115
2018-12-31 $122
2018-09-30 $130
2018-06-30 $65
2018-03-31 $38
2017-12-31 $46
2017-09-30 $46
2017-06-30 $54
2017-03-31 $61
2016-12-31 $67
2016-09-30 $73
2016-06-30 $56
2016-03-31 $61
2015-12-31 $64
2015-09-30 $70
2015-06-30 $77
2015-03-31 $79
2014-12-31 $87
2014-09-30 $54
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2012-12-31 $63
2011-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.467B $0.007B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.915B 16.40
Bristol Myers Squibb (BMY) United States $136.418B 11.40
Gilead Sciences (GILD) United States $95.859B 12.43
CSL (CSLLY) Australia $91.400B 0.00
Vertex Pharmaceuticals (VRTX) United States $77.539B 53.31
Regeneron Pharmaceuticals (REGN) United States $70.508B 27.18
Illumina (ILMN) United States $54.702B 56.21
Biogen (BIIB) United States $43.791B 7.50
Seattle Genetics (SGEN) United States $30.490B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.834B 10.67
Incyte (INCY) United States $23.618B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.144B 209.80
Moderna (MRNA) United States $22.678B 0.00
Genmab (GMAB) Denmark $22.443B 18.48
Genmab (GNMSF) Denmark $21.119B 62.70
Alnylam Pharmaceuticals (ALNY) United States $18.457B 0.00
BioNTech SE (BNTX) Germany $15.689B 0.00
BeiGene (BGNE) Cayman Islands $15.289B 0.00
Galapagos (GLPG) Belgium $13.179B 38.77
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Exact Sciences (EXAS) United States $12.938B 0.00
Sarepta Therapeutics (SRPT) United States $12.782B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.536B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.930B 26.90
Bio-Techne Corp (TECH) United States $10.196B 67.36
QIAGEN (QGEN) Netherlands $9.837B 28.60
Immunomedics (IMMU) United States $9.504B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.884B 0.00
Guardant Health (GH) United States $8.066B 0.00
Exelixis (EXEL) United States $7.167B 25.13
Ascendis Pharma (ASND) Denmark $7.083B 0.00
Repligen (RGEN) United States $6.493B 113.89
Novavax (NVAX) United States $6.060B 0.00
Adaptive Biotechnologies (ADPT) United States $5.907B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.664B 121.88
Acceleron Pharma (XLRN) United States $5.535B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.242B 0.00
Vir Biotechnology (VIR) United States $5.229B 0.00
Reata Pharmaceuticals (RETA) United States $5.173B 0.00
Mirati Therapeutics (MRTX) United States $5.123B 0.00
Zai Lab (ZLAB) China $4.812B 0.00
Emergent Biosolutions (EBS) United States $4.691B 30.75
MyoKardia (MYOK) United States $4.390B 0.00
MorphoSys AG (MOR) Germany $4.341B 33.67
China Biologic Products (CBPO) China $4.210B 23.40
Blueprint Medicines (BPMC) United States $4.183B 0.00
Amicus Therapeutics (FOLD) United States $4.094B 0.00
Global Blood Therapeutics (GBT) United States $4.077B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.974B 0.00
Inovio Pharmaceuticals (INO) United States $3.809B 0.00
Halozyme Therapeutics (HALO) United States $3.774B 0.00
NeoGenomics (NEO) United States $3.727B 272.15
Bluebird Bio (BLUE) United States $3.577B 0.00
Arena Pharmaceuticals (ARNA) United States $3.212B 0.00
Alkermes (ALKS) Ireland $3.189B 62.78
Deciphera Pharmaceuticals (DCPH) United States $3.067B 0.00
Fate Therapeutics (FATE) United States $2.915B 0.00
Denali Therapeutics (DNLI) United States $2.813B 0.00
Insmed (INSM) United States $2.794B 0.00
Amarin (AMRN) Ireland $2.598B 0.00
PHARMA MAR SA (PHMMF) Spain $2.479B 0.00
Viela Bio (VIE) United States $2.157B 0.00
UniQure (QURE) Netherlands $2.027B 0.00
Twist Bioscience (TWST) United States $2.000B 0.00
Eidos Therapeutics (EIDX) United States $1.917B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.903B 0.00
Principia Biopharma (PRNB) United States $1.877B 0.00
Alector (ALEC) United States $1.858B 0.00
Editas Medicine (EDIT) United States $1.777B 0.00
Ligand Pharmaceuticals (LGND) United States $1.762B 68.62
Zymeworks (ZYME) Canada $1.759B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.708B 0.00
I-Mab (IMAB) China $1.680B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Epizyme (EPZM) United States $1.630B 0.00
Intra-Cellular Therapies (ITCI) United States $1.614B 0.00
Mersana Therapeutics (MRSN) United States $1.562B 0.00
Cytokineticsorporated (CYTK) United States $1.549B 0.00
Sorrento Therapeutics (SRNE) United States $1.548B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.495B 0.00
Mesoblast (MESO) Australia $1.484B 0.00
Sangamo Therapeutics (SGMO) United States $1.482B 0.00
Beam Therapeutics (BEAM) United States $1.473B 0.00
Zealand Pharma (ZEAL) Denmark $1.464B 0.00
Revance Therapeutics (RVNC) United States $1.459B 0.00
Akcea Therapeutics (AKCA) United States $1.420B 0.00
REGENXBIO (RGNX) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.361B 0.00
Arvinas (ARVN) United States $1.307B 0.00
Coherus BioSciences (CHRS) United States $1.269B 8.86
Adaptimmune Therapeutics (ADAP) United Kingdom $1.259B 0.00
Intellia Therapeutics (NTLA) United States $1.235B 0.00
NantKwest (NK) United States $1.208B 0.00
Arcus Biosciences (RCUS) United States $1.166B 0.00
Athenex (ATNX) United States $1.086B 0.00
Compugen (CGEN) Israel $1.082B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.000B 0.00
Alcobra (ARCT) United States $0.988B 0.00
Retrophin (RTRX) United States $0.902B 0.00
Myriad Genetics (MYGN) United States $0.862B 44.46
Heska (HSKA) United States $0.852B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Pharming Group (PHGUF) Netherlands $0.826B 22.00
Cara Therapeutics (CARA) United States $0.819B 0.00
Dynavax Technologies (DVAX) United States $0.813B 0.00
Morphic Holding (MORF) United States $0.776B 0.00
VBI Vaccines (VBIV) United States $0.775B 0.00
Intrexon (PGEN) United States $0.775B 0.00
Kadmon Holdings (KDMN) United States $0.757B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.738B 0.00
Codexis (CDXS) United States $0.727B 0.00
Castle Biosciences (CSTL) United States $0.704B 0.00
Frequency Therapeutics (FREQ) United States $0.696B 0.00
Cellectis S.A (CLLS) France $0.693B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.689B 0.00
Agenus (AGEN) United States $0.670B 0.00
Vericel (VCEL) United States $0.662B 122.33
Cue Biopharma (CUE) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.629B 5.39
AnaptysBio (ANAB) United States $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.605B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Kala Pharmaceuticals (KALA) United States $0.583B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.557B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.557B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Athersys (ATHX) United States $0.540B 0.00
Syros Pharmaceuticals (SYRS) United States $0.529B 0.00
Cel-Sci (CVM) United States $0.519B 0.00
Anika Therapeutics (ANIK) United States $0.512B 16.48
NextCure (NXTC) United States $0.512B 0.00
Scholar Rock Holding (SRRK) United States $0.509B 0.00
UROGEN PHARMA (URGN) United States $0.509B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.508B 0.00
Clovis Oncology (CLVS) United States $0.506B 0.00
Protagonist Therapeutics (PTGX) United States $0.503B 0.00
DBV Technologies S.A (DBVT) France $0.502B 0.00
AC Immune SA (ACIU) Switzerland $0.492B 0.00
Merus (MRUS) Netherlands $0.450B 0.00
Geron (GERN) United States $0.445B 0.00
MeiraGTx Holdings (MGTX) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.437B 22.95
Precision BioSciences (DTIL) United States $0.429B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Seres Therapeutics (MCRB) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.406B 0.00
Avid Bioservices (CDMO) United States $0.390B 0.00
MannKind (MNKD) United States $0.386B 0.00
Albireo Pharma (ALBO) United States $0.383B 0.00
CytomX Therapeutics (CTMX) United States $0.378B 0.00
ANI Pharmaceuticals (ANIP) United States $0.371B 7.35
Kamada (KMDA) Israel $0.369B 15.33
WAVE Life Sciences (WVE) Singapore $0.344B 0.00
PDL BioPharma (PDLI) United States $0.335B 287.50
Affimed (AFMD) Germany $0.335B 0.00
OSMOTICA PHARM (OSMT) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.318B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Prometic Life Sciences (LMNL) Canada $0.309B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Abeona Therapeutics (ABEO) United States $0.285B 0.00
Celldex Therapeutics (CLDX) United States $0.284B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Spero Therapeutics (SPRO) United States $0.282B 0.00
ChromaDex (CDXC) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.270B 0.00
IBio (IBIO) United States $0.266B 0.00
IVERIC Bio (ISEE) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.254B 0.00
Northwest Biotherapeutics (NWBO) United States $0.254B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.248B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Selecta Biosciences (SELB) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.236B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.231B 0.00
Five Prime Therapeutics (FPRX) United States $0.228B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.223B 0.00
Liquidia Technologies (LQDA) United States $0.223B 0.00
XOMA (XOMA) United States $0.220B 0.00
Pluristem Therapeutics (PSTI) Israel $0.218B 0.00
Aptinyx (APTX) United States $0.216B 0.00
Aduro Biotech (ADRO) United States $0.212B 0.00
GENFIT S.A (GNFT) France $0.211B 0.00
Exicure (XCUR) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.203B 3.06
Bellus Health (BLU) Canada $0.200B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.193B 0.00
Trevena (TRVN) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.174B 0.00
Aytu Bioscience (AYTU) United States $0.162B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Kindred Biosciences (KIN) United States $0.152B 0.00
Cyclerion Therapeutics (CYCN) United States $0.151B 0.00
CorMedix Inc (CRMD) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.149B 0.00
TELA Bio (TELA) United States $0.145B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Biofrontera AG (BFRA) Germany $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.123B 0.00
Celsion (CLSN) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.121B 0.00
Oncobiologics (OTLK) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.05
Enzo Biochem (ENZ) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
AIT Therapeutics (XAIR) United States $0.116B 0.00
Eton Pharmaceuticals (ETON) United States $0.112B 0.00
AquaBounty Technologies (AQB) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Cardiff Oncology (CRDF) United States $0.097B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
DiaMedica Therapeutics (DMAC) United States $0.095B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.083B 0.00
Organovo Holdings (ONVO) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Unum Therapeutics (UMRX) United States $0.074B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Signal Genetics (MGEN) United States $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Curis (CRIS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
OvaScience (MLND) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Spherix (AIKI) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00